The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nosocomial Infection Treatment Market Research Report 2025

Global Nosocomial Infection Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1896822

No of Pages : 106

Ask Your Query
Synopsis
Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital.
The global Nosocomial Infection Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Nosocomial Infection Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nosocomial Infection Treatment.
Report Scope
The Nosocomial Infection Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nosocomial Infection Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nosocomial Infection Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Bayer
Becton, Dickinson and Company
Belimed
BioMerieux
Cantel
Cepheid
Getinge Group
Kimberly-Clark Corp.
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
BioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc.
Advanced Sterilization Products
Matachana Group
Segment by Type
Antibacterial Treatment
Antiviral Treatment
Antifungal Treatment
Segment by Application
Ventilator Associated Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
Gastrointestinal Infection
MRSA
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nosocomial Infection Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nosocomial Infection Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterial Treatment
1.2.3 Antiviral Treatment
1.2.4 Antifungal Treatment
1.3 Market by Application
1.3.1 Global Nosocomial Infection Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Ventilator Associated Pneumonia
1.3.3 Urinary Tract Infection
1.3.4 Blood Stream Infection
1.3.5 Surgical Site Infection
1.3.6 Gastrointestinal Infection
1.3.7 MRSA
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nosocomial Infection Treatment Market Perspective (2019-2030)
2.2 Nosocomial Infection Treatment Growth Trends by Region
2.2.1 Global Nosocomial Infection Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nosocomial Infection Treatment Historic Market Size by Region (2019-2024)
2.2.3 Nosocomial Infection Treatment Forecasted Market Size by Region (2025-2030)
2.3 Nosocomial Infection Treatment Market Dynamics
2.3.1 Nosocomial Infection Treatment Industry Trends
2.3.2 Nosocomial Infection Treatment Market Drivers
2.3.3 Nosocomial Infection Treatment Market Challenges
2.3.4 Nosocomial Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nosocomial Infection Treatment Players by Revenue
3.1.1 Global Top Nosocomial Infection Treatment Players by Revenue (2019-2024)
3.1.2 Global Nosocomial Infection Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Nosocomial Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nosocomial Infection Treatment Revenue
3.4 Global Nosocomial Infection Treatment Market Concentration Ratio
3.4.1 Global Nosocomial Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nosocomial Infection Treatment Revenue in 2023
3.5 Nosocomial Infection Treatment Key Players Head office and Area Served
3.6 Key Players Nosocomial Infection Treatment Product Solution and Service
3.7 Date of Enter into Nosocomial Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nosocomial Infection Treatment Breakdown Data by Type
4.1 Global Nosocomial Infection Treatment Historic Market Size by Type (2019-2024)
4.2 Global Nosocomial Infection Treatment Forecasted Market Size by Type (2025-2030)
5 Nosocomial Infection Treatment Breakdown Data by Application
5.1 Global Nosocomial Infection Treatment Historic Market Size by Application (2019-2024)
5.2 Global Nosocomial Infection Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nosocomial Infection Treatment Market Size (2019-2030)
6.2 North America Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nosocomial Infection Treatment Market Size by Country (2019-2024)
6.4 North America Nosocomial Infection Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nosocomial Infection Treatment Market Size (2019-2030)
7.2 Europe Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nosocomial Infection Treatment Market Size by Country (2019-2024)
7.4 Europe Nosocomial Infection Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nosocomial Infection Treatment Market Size (2019-2030)
8.2 Asia-Pacific Nosocomial Infection Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Nosocomial Infection Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nosocomial Infection Treatment Market Size (2019-2030)
9.2 Latin America Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nosocomial Infection Treatment Market Size by Country (2019-2024)
9.4 Latin America Nosocomial Infection Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nosocomial Infection Treatment Market Size (2019-2030)
10.2 Middle East & Africa Nosocomial Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Nosocomial Infection Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Nosocomial Infection Treatment Introduction
11.1.4 Abbott Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Nosocomial Infection Treatment Introduction
11.2.4 Bayer Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Detail
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Nosocomial Infection Treatment Introduction
11.3.4 Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 Belimed
11.4.1 Belimed Company Detail
11.4.2 Belimed Business Overview
11.4.3 Belimed Nosocomial Infection Treatment Introduction
11.4.4 Belimed Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.4.5 Belimed Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Nosocomial Infection Treatment Introduction
11.5.4 BioMerieux Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.5.5 BioMerieux Recent Development
11.6 Cantel
11.6.1 Cantel Company Detail
11.6.2 Cantel Business Overview
11.6.3 Cantel Nosocomial Infection Treatment Introduction
11.6.4 Cantel Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.6.5 Cantel Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Detail
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Nosocomial Infection Treatment Introduction
11.7.4 Cepheid Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.7.5 Cepheid Recent Development
11.8 Getinge Group
11.8.1 Getinge Group Company Detail
11.8.2 Getinge Group Business Overview
11.8.3 Getinge Group Nosocomial Infection Treatment Introduction
11.8.4 Getinge Group Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.8.5 Getinge Group Recent Development
11.9 Kimberly-Clark Corp.
11.9.1 Kimberly-Clark Corp. Company Detail
11.9.2 Kimberly-Clark Corp. Business Overview
11.9.3 Kimberly-Clark Corp. Nosocomial Infection Treatment Introduction
11.9.4 Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.9.5 Kimberly-Clark Corp. Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Detail
11.10.2 Merck & Co Business Overview
11.10.3 Merck & Co Nosocomial Infection Treatment Introduction
11.10.4 Merck & Co Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.10.5 Merck & Co Recent Development
11.11 Nordion
11.11.1 Nordion Company Detail
11.11.2 Nordion Business Overview
11.11.3 Nordion Nosocomial Infection Treatment Introduction
11.11.4 Nordion Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.11.5 Nordion Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nosocomial Infection Treatment Introduction
11.12.4 Pfizer Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.12.5 Pfizer Recent Development
11.13 Roche
11.13.1 Roche Company Detail
11.13.2 Roche Business Overview
11.13.3 Roche Nosocomial Infection Treatment Introduction
11.13.4 Roche Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.13.5 Roche Recent Development
11.14 Sakura Seiki
11.14.1 Sakura Seiki Company Detail
11.14.2 Sakura Seiki Business Overview
11.14.3 Sakura Seiki Nosocomial Infection Treatment Introduction
11.14.4 Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.14.5 Sakura Seiki Recent Development
11.15 BioMérieux
11.15.1 BioMérieux Company Detail
11.15.2 BioMérieux Business Overview
11.15.3 BioMérieux Nosocomial Infection Treatment Introduction
11.15.4 BioMérieux Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.15.5 BioMérieux Recent Development
11.16 Steris
11.16.1 Steris Company Detail
11.16.2 Steris Business Overview
11.16.3 Steris Nosocomial Infection Treatment Introduction
11.16.4 Steris Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.16.5 Steris Recent Development
11.17 Johnson & Johnson
11.17.1 Johnson & Johnson Company Detail
11.17.2 Johnson & Johnson Business Overview
11.17.3 Johnson & Johnson Nosocomial Infection Treatment Introduction
11.17.4 Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.17.5 Johnson & Johnson Recent Development
11.18 Sterigenics International, Inc.
11.18.1 Sterigenics International, Inc. Company Detail
11.18.2 Sterigenics International, Inc. Business Overview
11.18.3 Sterigenics International, Inc. Nosocomial Infection Treatment Introduction
11.18.4 Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.18.5 Sterigenics International, Inc. Recent Development
11.19 Halyard Health, Inc.
11.19.1 Halyard Health, Inc. Company Detail
11.19.2 Halyard Health, Inc. Business Overview
11.19.3 Halyard Health, Inc. Nosocomial Infection Treatment Introduction
11.19.4 Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.19.5 Halyard Health, Inc. Recent Development
11.20 Advanced Sterilization Products
11.20.1 Advanced Sterilization Products Company Detail
11.20.2 Advanced Sterilization Products Business Overview
11.20.3 Advanced Sterilization Products Nosocomial Infection Treatment Introduction
11.20.4 Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.20.5 Advanced Sterilization Products Recent Development
11.21 Matachana Group
11.21.1 Matachana Group Company Detail
11.21.2 Matachana Group Business Overview
11.21.3 Matachana Group Nosocomial Infection Treatment Introduction
11.21.4 Matachana Group Revenue in Nosocomial Infection Treatment Business (2019-2024)
11.21.5 Matachana Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock